Associations between endothelial nitric oxide synthase polymorphisms and risk of diabetic nephropathy: an updated meta-analysis

References

• Lee AS, Lee YJ, Lee SM, et al. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice. Am J Chin Med. 2012;40(3):495–510
   PubMed Web of Science ®Google Scholar
• Larsen T, Mose FH, Bech JN, Pedersen EB. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: A dose–response study in healthy man. Clin Exp Hypertens. 2012;4(8):567–574
   Web of Science ®Google Scholar
• Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147(Suppl 1):S193–S201
   PubMed Web of Science ®Google Scholar
• Wang Y, Marsden PA. Nitric oxide synthases: Biochemical and molecular regulation. Curr Opin Nephrol Hypertens. 1995;4(1):12–22
   PubMedGoogle Scholar
• Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev. 1998;14(3):241–249
   PubMed Web of Science ®Google Scholar
• Schwartz IF, Grupper A, Soetendorp H, et al. Attenuated glomerular arginine transport prevents hyperfiltration and induces HIF-1α in the pregnant uremic rat. Am J Physiol Renal Physiol. 2012;303(3):F396–F404
   PubMed Web of Science ®Google Scholar
• Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478–17488
   PubMed Web of Science ®Google Scholar
• Coory MD. Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2010; 39(3):932–933
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188
   PubMedGoogle Scholar
• Shoukry A, Shalaby SM, Abdelazim S, et al. Endothelial nitric oxide synthase gene polymorphisms and the risk of diabetic nephropathy in type 2 diabetes mellitus. Genet Test Mol Biomarkers. 2012;16(6):574–579
   PubMed Web of Science ®Google Scholar
• Santos KG, Crispim D, Canani LH, Ferrugem PT, Gross JL, Roisenberg I. Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes. Diabetes Res Clin Pract. 2011;91(3):353–362
   PubMed Web of Science ®Google Scholar
• Ahluwalia TS, Ahuja M, Rai TS, et al. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem. 2008;314(1–2):9–17
   PubMed Web of Science ®Google Scholar
• Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complications. 2008;22(5):331–338
   PubMed Web of Science ®Google Scholar
• Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000;57(2):405–413
   PubMed Web of Science ®Google Scholar
• Liao L, Zhao JJ, Lin MJ, Chen SW, Li GA. Association of a polymorphism in endothelial nitric oxide synthase gene T-786→C with diabetic nephropathy. Chin J Lab Med. 2006;29(2):146–147
   Google Scholar
• Asakimori Y, Yorioka N, Yamamoto I, et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron. 2001;89(2):219–223
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Vaisi-Raygani A, Rahimi Z, Parsian A. Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran. Nephrology (Carlton). 2012;17(2):175–181
   PubMed Web of Science ®Google Scholar
• Rao GF, Chen EF, Lin HY, Wu JY, Zeng AP. The correlation of eNOS gene polymorphism and susceptibility to diabetic nephropathy. China Modern Doctor. 2012;50(7):49–50
   Google Scholar
• Dai HS, Zhang Y. An association study of MTHFR and eNOS genes polymorphism with diabetic nephropathy. Chin J Trauma Disabil Med. 2012;20(6):4–6
   Google Scholar
• Tiwari AK, Prasad P, Thelma BK, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes. J Diabetes Complications. 2009;23(2):102–111
   PubMed Web of Science ®Google Scholar
• Tamemoto H, Ishikawa SE, Kawakami M. Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract. 2008;80(2):275–279
   PubMed Web of Science ®Google Scholar
• Ma JR, Yu DM, Liu DM. Study on the relationship between G894T mutation in endothelial constitutive nitric oxide synthase (ecNOS) gene and diabetic nephropathy. Tianjin Med J. 2006; 34(8):527–530
   Google Scholar
• Dong YH, Qu SP, Lv WS, et al. Gene polymorphism in chromosome 7q35 and susceptibility to diabetic nephropathy. Chin J Endocrinol Metab. 2005;21(1):47–50
   Google Scholar
• Fu ZJ, Li CG, Wang ZC, Yan SL. Coexistence of aldose reduction gene and endothelial nitric oxide synthase polymorphisms associates with diabetic nephropathy. J Clin Rehabil Tissue Eng Res. 2007;11(34):6893–6896
   Google Scholar
• Shin Shin Y, Baek SH, Chang KY, et al. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract. 2004;65(3):257–265
   PubMed Web of Science ®Google Scholar
• Li CG, Lv SY, Qi YQ, Wang L, Yan SL. Association study of 894G→T mutation at exon 7 of endothelial nitric oxide synthase gene and diabetic nephropathy with hypertension. Acta Acad Med Qingdao Univ. 2004;40(3):200–202
   Google Scholar
• Lv SY, Xing QQ, Li CG. Association between 894G-T polymorphism at exon 7 of endothelial nitric oxide synthase gene and diabetic nephropathy with or without hypertention. Chin J Mult Organ Dis Elderly. 2003;2(4):275–311
   Google Scholar
• Lv WS, Dong YH, Wang HY, Liu L, Si YG. A study of the association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy. Chin J Diabetes. 2002;10(2):81–84
   Google Scholar
• Möllsten A, Wessman M, Svensson M, et al. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann Med. 2006;38(7):522–528
   PubMed Web of Science ®Google Scholar
• Möllsten A, Lajer M, Jorsal A, Tarnow L. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol Genet Metab. 2009;97(1):80–84
   PubMed Web of Science ®Google Scholar
• Cai H, Wang X, Colagiuri S, Wilcken DE. A common Glu298–>Asp (894G–>T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care. 1998;21(12):2195–2196
   PubMed Web of Science ®Google Scholar
• El-Din Bessa SS, Hamdy SM. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. Ren Fail. 2011;33(9):878–884
   PubMed Web of Science ®Google Scholar
• Li XN, Yu MX, Wu XY, Shui H, Xiao JS. Association of endothelial nitric oxide synthase gene Glu298Asp polymorphism with diabetic kidney disease. J Clin Nephrol. 2011;11(8):351–353
   Google Scholar
• Wang ZC. The Study of the Relationship Between Glu298Asp (894G→T) Single Nucleotide Polymorphisims at Exon 7 of the Human Endothelial Cell Nitric Oxide Synthase (heNOS) Gene and Diabetic Nephropathy. Qingdao, China:QingDao University; 2004
   Google Scholar
• Nagase S, Suzuki H, Wang Y, et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003;244(1–2):113–118
   PubMed Web of Science ®Google Scholar
• Thaha M, Pranawa, Yogiantoro M, Sutjipto, et al. Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin Nephrol. 2008;70(2):144–154
   PubMed Web of Science ®Google Scholar
• Suzuki H, Nagase S, Kikuchi S, Wang Y, Koyama A. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem. 2000;46(11):1858–1860
   PubMed Web of Science ®Google Scholar
• Guo XJ, Liu SJ. The association between endothelial nitric oxide synthase gene polymorphism and type 2 diabetic nephropathy. Natl Med Front China. 2011;6(19):3–5
   Google Scholar
• Dong JJ, Zhao JJ, Lee KO, Lim MC, Chan SW, Liao L. Distribution of polymorphism in endothelial nitric oxide synthase gene in mainland Chinese and Singapore Chinese and its association with diabetic nephropathy. Natl Med J China. 2007;87(48):3415–3417
   Google Scholar
• Zhang M, Liu H, Yang HY, Wang YM, Song DP, Li H. Relationship of endothelial nitric oxide synthase (eNOS) 4a/b gene polymorphism with diabetic nephropathy in T2DM. Chin J Diabetes. 2005;13(4):284–285
   Google Scholar
• Xing Q, Su BL, Li CC, et al. Association between endothelial nitric oxide synthase gene polymorphism and type 2 diabetic nephropathy. Chin J Endocrinol Metab. 2004;20(5):435–437
   Google Scholar
• Sun HY, Yang MG, Liu SQ, et al. Study on the correlation of the polymorphisms of endothelial nitric oxide synthase gene with type 2 diabetes mellitus and diabetic nephropathy. Chin J Prev Contr Chron Non-commun Dis. 2004;12(3):101–103
   Google Scholar
• Luo H, Ning YY. Relationship between gene polymorphism of endothelial nitricoxide synthase and early intervention of patients with diabetic nephropathy. Chin J Clin Rehabil. 2003;7(12):1766–1767
   Google Scholar
• Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract. 2002;58(3):179–185
   PubMed Web of Science ®Google Scholar
• Li CG, Yang NL. The correlation between PAI-1 promoter 4G/5G and the intron 4 of eNOS gene polymorphism and diabetic nephropathy. Shandong Med J. 2002;42(17):16–18
   Google Scholar
• Lin S, Qu H, Qiu M. Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population. Nephron. 2002;91(4):768
   PubMedGoogle Scholar
• Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, Nishizawa Y. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 2001;24(9):1653–1660
   PubMed Web of Science ®Google Scholar
• Lv WS, Dong YH, Li CG, Liu L, Wang HY, Si YG. A study of association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy. J Weifang Med Coll. 2001;23(4):278–280
   Google Scholar
• Asakimori Y, Yorioka N, Taniguchi Y, et al. T(-786)–>C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron. 2002;91(4):747–751
   PubMed Web of Science ®Google Scholar
• Fujita H, Narita T, Meguro H, et al. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res. 2000;32(2):80–83
   PubMed Web of Science ®Google Scholar
• Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes. 2000;49(3):500–503
   PubMed Web of Science ®Google Scholar
• Shestakova MV, Koshel' LV, Vagodin VA, Dedov II. Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis. Ter Arkh. 2006;78(5):60–64
   PubMed Web of Science ®Google Scholar
• Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC. Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia. 2003;46(3):426–428
   PubMed Web of Science ®Google Scholar
• Ksiazek P, Wojewoda P, Muc K, Buraczynska M. Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn. 2003;7(2):119–123
   PubMedGoogle Scholar
• Frost D, Chitu J, Meyer M, Beischer W, Pfohl M. Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients. Exp Clin Endocrinol Diabetes. 2003;111(1):12–15
   PubMed Web of Science ®Google Scholar
• Degen B, Schmidt S, Ritz E. A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant. 2001;16(1):185
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Shahvaisi-Zadeh F, Sadeghei S, Vessal M, Yavari N. eNOS 4a/b polymorphism and its interaction with eNOS G894T variants in type 2 diabetes mellitus: Modifying the risk of diabetic nephropathy. Disease Markers. 2013;34(6):437–443
   PubMed Web of Science ®Google Scholar
• Lamnissou K, Zirogiannis P, Trygonis S, et al. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus. Genet Test. 2004;8(3):319–324
   PubMedGoogle Scholar
• Bellini MH, Figueira MN, Piccoli MF, et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology (Carlton). 2007;12(3):289–293
   PubMed Web of Science ®Google Scholar
• Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245(1):190–193
   PubMed Web of Science ®Google Scholar